2023 FALL CONFERENCE REGISTRATION NOW OPEN

Save Before August 31

Registration is now open for the 2023 AAN Fall Conference, offered October 27 through 29 both in person at the Paris Las Vegas Hotel and online. No matter how you attend, the conference will promise innovative programming with updates on relevant neurologic topics, practice management and science sessions, and opportunities to earn valuable end-of-year CME. If joining us in person, you’ll also have opportunities to network with colleagues and external companies that have products and services to advance your practice and improve patient care.

Early registration savings end August 31. To get an even better value— and gain extended access to session recordings, program materials, and ability to claim CME through August 1, 2024—consider adding Fall Conference On Demand to your registration for a savings of up to 55-percent off the standalone On Demand price.

Capitol Hill Report: FDA Approves Lecanemab for Alzheimer’s

On July 6, the Food and Drug Administration (FDA) granted traditional approval to lecanemab, brand name Leqembi, for the treatment of Alzheimer’s disease (AD).

This much anticipated traditional approval will significantly change the availability of the drug that had originally gained accelerated approval in January of this year, as it will now be covered in the context of “prospective comparative studies” which promise to be much less burdensome on patients and providers alike than the previous coverage option which necessitates participation in randomized controlled trials to gain access to the drug. Coverage issues impacting this product have been of significant interest both to regulators and to members of Congress.

The distinction between these coverage options can be found in the National Coverage Determination (NCD) published in April of 2022 which restricts access to all monoclonal

Call for Abstracts for the 2024 Annual Meeting

Abstract submission for the 2024 Annual Meeting opens later this month. Visit AAN.com/AMAbstracts to learn more and submit your breakthrough research.

Abstracts will be accepted until 11:59 p.m. CT on October 17, 2023, in all subspecialties and career levels. The non-refundable submission fee is $125 for AAN members and $225 for nonmembers. Submission is free for residents and medical students. For more information, contact Katie Anderson at science @ aan.com 

The Mission of the AAN is to promote the highest quality patient-centered neurologic care and enhance member career satisfaction.

The Vision of the AAN is to be indispensable to our members.

Contact Information

American Academy of Neurology

201 Chicago Avenue Minneapolis, MN 55415

Phone: (800) 879-1960 (toll free) (612) 928-6000 (international)

Email: memberservices@ aan.com

Website: AAN.com

For advertising rates, contact: Michael J. O’Brien II

Account/Relationship Manager

Wolters Kluwer

Phone: (978) 578-4514

Email: Michael.Obrien @ wolterskluwer.com